Author: Customer Service

MIAMI, FL , March 26, 2026 (GLOBE NEWSWIRE) — RenX Enterprises Corp. “RenX” (NASDAQ: RENX), a  biomass recycling, logistics, and real estate company, today announced that it has received written confirmation from MTDH Germany GmbH (“Microtec”) that the  UTM 1200 Turbo Mill ordered by the Company has been completed at the Microtec manufacturing facility and is being prepared for shipment from Germany to RenX’s Myakka City, Florida facility. Delivery to the site is expected in April 2026, as the Company works to finalize site preparation and coordinate installation logistics. The Microtec UTM 1200 is the primary size-reduction component of the Microtec milling system, a 12-step engineered processing circuit designed to process up to 10 tons per hour of woody biomass screened from compost and produce three specification-defined particle...

HOUSTON and TORRANCE, Calif., March 26, 2026 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), the advanced battery intelligence solution for autonomous platforms, digital infrastructure, e-mobility, and spaceflight applications, today announces a strategic co-development collaboration with Robinson Helicopter Company (RHC), the world’s leading manufacturer of civil helicopters, to develop a next-generation, high-performance battery system for an eR66 battery-electric helicopter demonstrator.Under the agreement, KULR is expected to serve as a developer of the advanced battery system for the eR66 platform. The Company intends to design and integrate a lightweight, high-performance battery architecture using KULR’s proprietary battery safety technologies...

HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) — Pluri Inc. (“Pluri” or the “Company”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging a proprietary cell-based platform across multiple commercial verticals, today announced that an entity beneficially owned by Alejandro Weinstein, Chairman of the Board and one of the Company’s largest shareholders, has entered into a Securities Purchase Agreement with Pluri for an additional $2.5 million investment in the Company at a 30% premium to the market price on March 24, 2026. This additional investment follows Mr. Weinstein’s prior $2.5 million investment announced in connection with his appointment as Chairman of the Board, and further underscores his continued support in Pluri’s strategy, underlying asset base, and long-term value creation opportunity. “Making an additional...

– Closes Private Placement Financing of Up to $104.5 Million – Secures Orphan Drug Designations for QRX003 for Netherton Syndrome (NS) in the U.S. and Europe  – Advances Proposed Expedited Regulatory Approval Pathways in Japan and Saudi Arabia and Secures Fast Track Designation in the U.S. for QRX003 for NS Subsequent to the End of Q4 – Reports Continued Clinical Progress for QRX003 in Netherton Syndrome Clinical Studies including Data Supporting Longer Term Durable Treatment Effect and Safety Profile – Pediatric NS Study Expanded to 7 Children Now Actively Treated with QRX003, Largest Cohort of This Age Group Ever Studied – Ongoing Clinical Data Continues to Support Development of QRX003 as a Treatment for Peeling Skin Syndrome with Study Being Expanded to 6 Subjects – Proprietary Rapamycin Topical Platforms Achieve Target Loadings;...

Two-year master task agreement expands Perma-Fix’s nuclear services project portfolio and reinforces its long-standing relationship supporting work at LLNL ATLANTA, March 26, 2026 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced it has been awarded a two-year master task agreement valued at approximately $24 million by Lawrence Livermore National Security, LLC (“LLNS”) for demolition and disposal at Lawrence Livermore National Laboratory (“LLNL”) in Livermore, California. Under the agreement, Perma-Fix will provide demolition, excavation, and waste management services to support the safe disposition of these facilities as part of site efforts aligned with LLNL’s national security mission. The project is expected to draw on Perma-Fix’s technical expertise in complex radiological...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) — CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the filing of two new patent applications that further expand the Company’s intellectual property portfolio surrounding tapinarof, a drug currently approved for the treatment of psoriasis and atopic dermatitis. The first newly filed patent covers a combination therapy pairing tapinarof with a class of drugs clinically proven in psoriasis and atopic dermatitis, while the second patent relates to novel cocrystal forms of tapinarof with these agents. CDT believes these developments may underpin a second-generation tapinarof product with enhanced formulation properties and potential efficacy benefits, creating an opportunity to extend the asset’s lifecycle and broaden its clinical and...

Company Positions for Growth with AI-Driven Media, Marketing, Digital Asset Expansion CHICAGO, March 26, 2026 (GLOBE NEWSWIRE) — via IBN — Alliance Creative Group, Inc., (http://www.ACGX.us),  a technology-driven holding company focused on AI-powered media, marketing, and digital assets (Stock Symbol OTC:ACGX) is pleased to announce the results of Operations for the Year Ending December 31, 2025. Gross Incomes for the Year ending December 31, 2025 (“2025”) were $364,082 Expenses for the Year ending December 31, 2025 (“2025”) were $282,813 Net Income for the Year ending December 31, 2025 (“2025”) was $81,269 The total assets on the Balance Sheet for the Alliance Creative Group as of 12/31/25 were $1,066,929 The total outstanding common shares as of December 31, 2025 were 7,006,143 with 4,225,903...

TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using RenovoCath® as a Stand-Alone Device for Drug-Delivery in Oncology Management MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE) — RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced the Company has achieved a key milestone in its ongoing Phase III TIGeR‑PaC clinical trial by surpassing 100 randomized patients and remains on track for enrollment completion in the first half of 2026, with final data expected in 2027. “Reaching over 100 randomized patients marks an important milestone in our Phase III...

     According to the Rain Foundation, anyone using OpenClaw or other AI agents can generate a live prediction market via a single prompt to the agent, without manual coding or centralized gatekeepers      The Rain Foundation announced a $5 million grant program to support developers and creators worldwide in building, launching, and monetizing their own independent prediction markets via the Rain decentralized platform through AI agentsNes-Ziona, Israel, March 26, 2026 (GLOBE NEWSWIRE) — Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or “the Company”), a quality longevity company powered by a prediction markets treasury, today reported that the Rain Foundation, which independently oversees the decentralized prediction markets Rain protocol, announced the launch of its AI agent-ready interface and a $5 million grant program to support...

BOCA RATON, FL, March 26, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (“DFDV” or the “Company”), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced the successful completion of its March 2026 community Ask Me Anything (AMA) session hosted on Reddit. The AMA, held on March 23, 2026, provided an open forum for the Company’s management team to engage directly with its community and investors. Topics discussed included DFDV’s treasury strategy, Solana ecosystem developments, validator operations, digital asset treasury (DAT) expansion initiatives, and ongoing product innovation across its onchain yield and tokenization efforts. The AMA can be accessed here: https://www.reddit.com/r/DFDVDegens/comments/1rx5ve5/mar_2026_official_dfdv_ama_ask_the_team_anything/. The...